Bharat Immunologicals Financial Statements Trends

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 24.8  0.2  0.81%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Price to Book Analysis

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is accounting value of assets minus liabilities.
Bharat Immunologicals 
P/B 
 = 
MV Per Share 
BV Per Share 
 = 
2.5 times

About Price to Book

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Compare to competition
Based on latest financial disclosure the price to book indicator of Bharat Immunologicals Biologicals Corp Ltd is roughly 2.5 times. This is much higher than that of the sector, and significantly higher than that of Price to Book industry, The Price to Book for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in gross profit category among related companies. It is rated below average in total debt category among related companies making up about  1.49  of Total Debt per Gross Profit.

Peer Comparison

Bharat Immunologicals Operating Margin Comparison
Bharat Immunologicals is currently under evaluation in operating margin category among related companies.

Did you try this?

Run Fundamental Analysis Now
   

Fundamental Analysis

View fundamental data based on most recent published financial statements
Hide  View All  NextLaunch Fundamental Analysis

Fundamental Indicators

Current Bharat Immunologicals financial ratios